MedMarket Diligence, LLC

Competing against sutures and staples, advanced wound closure, sealing, hemostasis and anti-adhesion products are steadily gaining revenues. A new February 2012 report from MedMarket Diligence details this global $14 billion market.

Products for hemostasis, sealing, closure and other wound management reflect diverse technologies, as advanced types steadily make inroads in to traditional wound products. MedMarket Diligence has published its 2012 global analysis of this market.

Competitors in the market for adjunctive wound securement products are seeking to grow and/or expand their presence and revenue streams in the medical and surgical wound management market. MedMarket Diligence forecasts the market opportunity.

Global markets for devices in spine surgery are ripe with innovation and continue to offer up opportunities despite cost pressures, a challenging economic climate and uncertain regulatory trends, according to a new report from MedMarket Diligence.

Spine surgery, like all medtech markets, is under immense pressure to rein in costs, yet unabated market drivers and innovation by manufacturers make spine surgery a continued strong market opportunity, according to a new MedMarket DIligence report.

Too much attention has been given to recent setbacks for drugs in obesity treatment and not enough has been paid to the persistent opportunities for the many pending pending devices and drugs. A 2011 MedMarket Diligence report details the outlook.

Technologies as varied as ultrasound, radiofrequency, hydromechanical and others for the energy-based treatment of tissue are finding an equally broad range of applications in nearly all medical specialties. The result is a $10 billion global market.

Cell therapy has generated a great deal of headlines. Meanwhile, tissue engineering has generated a great deal of revenue.

Treatments via cell therapy and tissue engineering constitute a $6.9 billion worldwide market as they have become a major thrust of new clinical practices in nearly all major medical specialties, according to a new MedMarket Diligence report.

Stem cell and other pluripotentent cells, biomaterials and other products providing cell- and tissue-based regeneration and therapy are actively under development by hundreds of companies, according to a new report by MedMarket Diligence, LLC.